CLDF Title
Home | Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Reuters Health Information (2006-09-05): Imaging unreliable for detection of colorectal liver cancer metastases


Imaging unreliable for detection of colorectal liver cancer metastases

Last Updated: 2006-09-05 15:33:24 -0400 (Reuters Health)

NEW YORK (Reuters Health) - A complete response on CT scan is not conclusive in assessing the presence of metastases after chemotherapy for colorectal liver metastases, French researchers report in the August 20th issue of the Journal of Clinical Oncology.

Dr. Stephane Benoist and colleagues at the Hopital Ambroise Pare in Boulogne studied 38 patients treated for colorectal liver metastases in their institution. Eligibility for the study included fewer than 10 liver metastases before chemotherapy, disappearance of one or several spots on CT scan and ultrasound after chemotherapy, surgery with intra-operative ultrasound within four weeks, no hepatic disease and follow-up at least one year after surgery.

There were a total of 183 liver metastases before chemotherapy and 66 disappeared afterward as assessed by CT scan. Dr. Benoist and colleagues found persistent macroscopic disease at the site of surgery in 20 of the 66 liver metastases.

Of 31 liver metastases considered completely cured after surgery by intraoperative imaging, 23 had recurred in situ.

Overall, there was persistent macroscopic or microscopic residual disease or early recurrence in 55 of the 66 index liver metastases, or 83%.

Dr. Benoist notes that there was macroscopic evidence of disease on exploratory surgery in more than 25% of cases and microscopic disease was found in 80% of patients with no obvious disease.

"The major question for the surgeon is whether the site of metastases that have disappeared should be included in the resection or be left in place," the authors write. "This study demonstrated that microscopic cancer persists in most of these sites...Thus, in most cases, resection of the of the sites of initial metastases is necessary."

J Clin Oncol 2006;24:3939-3945.

Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2017 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.